mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.092 |
0.04 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.04 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.05 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.05 |